JRI 

Elham Safarpour
- Department of Biology, Faculty of Sciences, Islamic Azad University, Science & Research Campus, Tehran, Iran
Kazem Parivar
- Department of Biology, Faculty of Sciences, Islamic Azad University, Science & Research Campus, Tehran, Iran
Mohammad Mehdi Akhondi
- Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Mahmood Jeddi-Tehrani
- Monoclonal Antibody Research Center, Avicenna Research Institute (ACECR), Tehran, Iran
Fazel Shokri
1- Monoclonal Antibody Research Center, Avicenna Research Institute (ACECR), Tehran, Iran
2- Immunology Department, Faculty of Medical Science, Tehran University of Medical Science, Tehran, Iran
Amir Hassan Zarnani
1- Nanobiotechnology Research Center, Avicenna Research Institute (ACECR), Tehran, Iran
2- Department of Immunology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
Mohammad Keramatipour
- Faculty of Medical Tehran University of Medical Sciences, Tehran, Iran
Sheida Salehkhou
- Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Leila Eini
- Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Mohammad Reza Sadeghi Corresponding Author
- Monoclonal Antibody Research Center, Avicenna Research Institute (ACECR), Tehran, Iran

Received: 1/1/2007 Accepted: 1/1/2007 - Publisher : Avicenna Research Institute

Related Articles

 

Other Format

 


Abstract

Introduction: Stem cell therapy seems promising for the treatment of incurable diseases such as injured myocardium. Directed in vitro differentiation of embryonic stem cells (ES) to cardiomyo-cytes is invaluable. TGFβ-2 and BMP-2, two different growth factors from the transforming growth factor-β superfamily (TGF-β), exhibit their effects on growth, immigration and different-tiation and other cellular functions during embryonic development. In this study, the effects of these factors on differentiation of ES cells into cardiomyocytes were evaluated. Materials & Methods: Murine embryonic stem cells (CCB derived from mouse strain 129) were used for cardiomyocyte differentiation. To increase the effects of the factors, ES cells were grown on inactivated fibroblasts for 24 hours in differentiating culture medium containing 8 ng/ml of TGF-β2 and 5 ng/ml of BMP-2 while decreasing serum concentration from 20% to 7.5%. Later, embryoid bodies (EB) were formed in 800-cells hanging drops and suspension from ES cells and eventually, EBs were cultured on gelatin-coated plates. After continuation of these steps, ES cells differentiated into beating cells. To determine the effects of the growth factors on ES cell differen-tiation into cardiomyocytes, expression of primary transcribing factors, MEF2, Nkx2.5, and specific cardiac genes including MHC, ANF, MLC-2v were assessed by semiquantitative RT-PCR and expression of desmin and α-actinin in differentiated cardiomyocytes was studied by western blotting and immunostaining. Results: After completion of the differentiation process, the EBs in the experimental groups exhibited beating compared with the control group. Considering the quantitative comparison of the dectrophoretic bands of RT-PCR and PCR products of the plated EBs in different media, it was seen that TGF-2 from BMP-2 and both factors together, compared to each one alone, is more effective on differentiation of embryonic stem cells into cardiomyocytes. In addition, in plated EBs, in a medium containing both factors, the expression of desmin and -actinin were determined by western blotting and the presence of cardiomyocytes, by marking desmin, by immunohistochemical staining. Conclusion: The results showed that the synchronized effects of both factors, while decreasing serum concentration during ES and EB cell cultures, increases differentiation of ES cells into cardiomyocytes.


Keywords: Embryonic stem cell, Differentiation, Cardiomyocyte, TGF-B2, BMP-2


To cite this article:


References

  1. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981; 292:154-156.   [PubMed]
  2. Doetschman TC, Eistetter H, Katz M. The in-vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol. 1985;87:27-45.   [PubMed]
  3. Boheler KR, Czyz J, Tweedie D. Differentiation of Pluripotent Embryonic Stem Cells Into Cardiomyo-cytes. Circ Res. 2002;91:189-201.   [PubMed]
  4. Ullao-Montoya F, Verfaillie C, Hu W. Culture systems for pluripotent stem cells. J Biosci Bioeng. 2005;100: 12-27.   [PubMed]
  5. Nichols J, Davidson D, Taga T. Complementary tissue-specific expression of LIF and LIF-receptor mRNAs in early mouse embryogenesis. Mech Dev. 1996;57:123-31.   [PubMed]
  6. Zandstra PW, Nagy A. Stem cell bioengineering. Annu Rev Biomed Eng. 2001;3:275-305. Review.   [PubMed]
  7. Kumar D, Kamp TJ, Lewinter M. Embryonic stem cells: differentiation into cardiomyocytes and potential for heart repair and regeneration, Coron. Artery Dis. 2005; 16:111-6.   [PubMed]
  8. Wobus AM, Wallukat G, Hescheler J. Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca 2+ channel blockers. Differentiation. 1991;48:173-182.   [PubMed]
  9. Wobus AM, Boheler KR, Embryonic Stem Cells: prospects for developmental biology and cell therapy. Physiol Rev. 2005;85:635-78.   [PubMed]
  10. Winkler J, Hescheler J, Sachinidis A. Embryonic stem cells for basic research and potential clinical applica-tions in cardiology. Biochim Biophys Acta. 2005;1740 (2):240-8.   [PubMed]
  11. Sachinidis AK, Fleischmann B, Kolossov E. Cardiac specific differentiation of mouse embryonic stem cells. Cardio Rese. 2003;58:278-291.   [PubMed]
  12. Kumar D, Sun B. TGF-beta 2 enhances differentia-tion of cardiac myocytes from embryonic stem cells. Biochem Biophys Res Commun. 2005;332:135-41.   [PubMed]
  13. Maltsev VA, Rohwedel J, Hescheler J. Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev. 1993;44:41-50.   [PubMed]
  14. Czyz J, Wobus AM. Embryonic stem cell differentia-tion: the role of extracellular factors. Differentiation. 2001;8:167-74.
  15. Schuldiner M, Yanuka O. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA. 2000;97:11307-11312.   [PubMed]
  16. Behfar A, Zingman LV, Hodgson DM. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J. 2002;16:1558-66.   [PubMed]
  17. Orkin SH. GATA-binding transcription factors in hematopoietic cells. Blood. 1992;80:575-581.   [PubMed]
  18. Simon MC. Gotta have GATA. Nat Genet. 1995;11:9-11.   [PubMed]
  19. Zhu J, Hill RJ, Heid PJ. End-1 encodes an apparent GATA factor that specifies the endoderm precursor in Caenorhabditis elegans embryos. Genes Dev. 1997;11: 2883-96.   [PubMed]

COPE
SID
NLM
AJMB
IJBMLE
IJBMLE

Home | About Us | Current Issue | Past Issues | Submit a Manuscript | Instructions for Authors | Subscribe | Search | Contact Us

"Journal of Reproduction & Infertility" is owned, published, and managed by Avicenna Research Institute .
Creative Commons License

This work is licensed under a Creative Commons Attribution –NonCommercial 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Journal of Reproductoin and Infertility (JRI) is a member of COMMITTEE ON PUBLICATION ETHICS . Verify here .

©2024 - eISSN : 2251-676X, ISSN : 2228-5482, For any comments and questions please contact us.